Maxim Group set a $5.00 price objective on SLS International (AMEX:SLS) in a research note issued to investors on Thursday morning. The brokerage currently has a buy rating on the biotechnology company’s stock.

A number of other brokerages also recently issued reports on SLS. Oppenheimer set a $13.00 price objective on shares of SLS International and gave the stock a buy rating in a research report on Thursday, November 15th. CIBC began coverage on shares of SLS International in a research report on Thursday, November 1st. They issued an outperform rating on the stock. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. The company presently has an average rating of Buy and a consensus price target of $5.81.

SLS International (AMEX:SLS) last posted its earnings results on Thursday, November 15th. The biotechnology company reported ($0.53) EPS for the quarter, missing analysts’ consensus estimates of ($0.36) by ($0.17).

About SLS International

SLS international is a language services company which offers translations globally. The Company offers a range of services, including multilingual translations into all Spanish variants, localization, adaptation and content editing. It uses the mother-tongue linguists in order to meet the demanding standards.

See Also: How Do I Invest in Dividend Stocks

Analyst Recommendations for SLS International (AMEX:SLS)

Receive News & Ratings for SLS International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SLS International and related companies with MarketBeat.com's FREE daily email newsletter.